Evidence map›Paper›PMID 17420213›Full record

ArticleAntimicrobial agents and chemotherapy2007

Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina.

Laurent Poirel, Stéphane Corvec, Melina Rapoport, Pauline Mugnier, Alejandro Petroni, Fernando Pasteran, Diego Faccone, Marcelo Galas, Henri Drugeon, Vincent Cattoir and 1 more

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. A Retrospective Analysis ofMicroorganisms · 2024
    Article
  3. Article
  4. CRISPR-Based Gene Editing inPharmaceuticals (Basel, Switzerland) · 2023
    Review
  5. Review
  6. Article
  7. Antibiogram Profile ofPathogens (Basel, Switzerland) · 2021
    Article
  8. Article
  9. Pathogens (Basel, Switzerland) · 2021
    Review
  10. Article
  11. Article
  12. Review
  13. Insights intoAntibiotics (Basel, Switzerland) · 2020
    Review
  14. Genetic Features of AntarcticFrontiers in cellular and infection microbiology · 2019
    Article
  15. New microbes and new infections · 2018
    Article
  16. Biology ofFrontiers in cellular and infection microbiology · 2017
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Laurent PoirelService de Bactériologie-Virologie, Hôpital de Bicêtre, 78 rue du Général Leclerc, 94275 Le Kremlin-Bicêtre cedex, France.
Stéphane Corvec
Melina Rapoport
Pauline Mugnier
Alejandro Petroni
Fernando Pasteran
Diego Faccone
Marcelo Galas
Henri Drugeon
Vincent Cattoir
Patrice Nordmann
Administración Nacional de Laboratorios e Institutos de Salud · ARBicêtre Hospital · FRCentre Hospitalier Universitaire de Nantes · FRAssistance Publique – Hôpitaux de Paris · FRUniversité Paris-Saclay · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

By studying the beta-lactamase content of several Acinetobacter spp. isolates from Argentina, producing the expanded-spectrum beta-lactamases (ESBL) VEB-1a or PER-2, a novel Ambler class A beta-lactamase gene was identified. It encoded the narrow-spectrum beta-lactamase SCO-1, whose activity was inhibited by clavulanic acid. SCO-1 hydrolyzes penicillins at a high level and cephalosporins and carbapenems at a very low level. beta-Lactamase SCO-1 was identified from unrelated VEB-1a-positive or PER-2-positive Acinetobacter spp. isolates recovered from three hospitals. The bla(SCO-1) gene was apparently located on a plasmid of ca. 150 kb from all cases but was not associated with any ESBL-encoding gene. The G+C content of the bla(SCO) gene was 52%, a value that does not correspond to that of the A. baumannii genome (39%). beta-Lactamase SCO-1 shares 47% amino acid identity with CARB-5 and ca. 40% with the enzymes TEM, SHV, and CTX-M. A gene encoding a putative resolvase was identified downstream of the bla(SCO-1) gene, but its precise way of acquisition remains to be determined.

Indexed as

beta-Lactamasesbeta-Lactam ResistanceAcinetobacterAcinetobacter InfectionsAmino Acid SequenceAnti-Bacterial AgentsArgentinabeta-LactamsClavulanic AcidCloning, MolecularHumansMicrobial Sensitivity TestsMolecular Sequence DataSequence Analysis, DNAAnti-Bacterial Agentsbeta-Lactamasesbeta-LactamsClavulanic Acid

Identifiers

PMID17420213
PMCPMC1891420
OpenAlexW2139967167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.